P. malariae , P. ovale , chloroquine(passive) caused byTreatment of uncomplicated malaria
P. ovale and P. malariae9.6(passive) caused bymalaria9.5 treatment of malaria
P. falciparum†(passive) caused byTreatment of severe malaria
conditionsleadingto malaria treatment failure
The Human Cost of a Pharmaceutical Anachronism Eyal Meltzer , Lindsay Morrison , Shmuel Stienlauf and Eli Schwartz https://doi.org/10.4269/ajtmh.14-0109 Confusion between salt / base forms of primaquinemay resultin malaria prophylaxis failure
accessto promptpresumptive treatment of malaria
factorsinfluencingtreatment outcome of malaria
the potentialto causemalaria treatment failure
this interactioncould leadto malaria treatment failure
p. 1 in the aspirin and extended release dipyridamole capsules group , 2(passive) caused bypediculi- treatment of malaria
from drug resistance , poor adherence or unusual pharmacokinetic properties in that individualmay resultfrom drug resistance , poor adherence or unusual pharmacokinetic properties in that individual
to allied complications like anemia , dysentery , kidney failure and enchaphalitis , coma and other profound alteration of general conditionmay leadto allied complications like anemia , dysentery , kidney failure and enchaphalitis , coma and other profound alteration of general condition
from poor patient drug com‐ pliance , inadequate dosing , pharmacokinetic ( PK ) , and pharmacodynamic ( PD ) factorsresultsfrom poor patient drug com‐ pliance , inadequate dosing , pharmacokinetic ( PK ) , and pharmacodynamic ( PD ) factors
from poor patient drug compliance , inadequate dosing , pharmacokinetic ( PK ) , and pharmacodynamic ( PD ) factorsresultsfrom poor patient drug compliance , inadequate dosing , pharmacokinetic ( PK ) , and pharmacodynamic ( PD ) factors
to death from Ebola infection in all animalsledto death from Ebola infection in all animals
to tonsillitis complicationscould leadto tonsillitis complications
in the 17th centurywas discoveredin the 17th century
from subsidised treatment in the under - fivesresultingfrom subsidised treatment in the under - fives